“We have been working towards a multi-indication PBS listing for nivolumab and ipilimumab with the PBAC since 2017. We have maintained momentum throughout this period as we have always understood the importance and impact of expedited access for Australian patients,” said Owen Smith, General Manager of Bristol Myers Squibb Australia and New Zealand. …
PBS listing expands access to immunotherapy for Australians with advanced cancer
March 1, 2026 Latest NewsBioPharmaNews of the Day
Latest Video
New Stories
-
The regulator that deleted the truth from its answers now wants to police the media
October 1, 2026 - - Latest News -
By the TGA's own test, the Health Minister's press releases are advertising
October 1, 2026 - - Latest News -
Eczema patients who don't respond to steroids get subsidised access to ointment
October 1, 2026 - - Latest News -
Vitrafy takes its frozen platelet push to America's Midwest
September 30, 2026 - - Australian Biotech -
Paradigm Biopharmaceuticals enters voluntary administration after Phase 3 setback
September 30, 2026 - - Australian Biotech -
FDA fast tracks Telix scan that could spare men prostate biopsies
September 30, 2026 - - Australian Biotech -
Australian broadcast personality reveals the scars shingles left behind
September 30, 2026 - - Latest News